DEVELOPING CUSTOMIZED RESEARCH SOLUTIONS

THROUGH INNOVATIVE
GENOMIC TECHNOLOGIES

Research

Our passion is to enable clinical discoveries through expert genomics research. With the advent of personalized medicine, the focus of genetic research is to assimilate, associate and relate a patient’s genomic information with diseases and therapeutics. We continually advance our understanding of genomes by working with our experienced scientists, and establishing collaborations with the top academic and medical institutions.

  • https://www.genome.com/wp-content/uploads/2017/11/comp1.png
    https://www.genome.com/wp-content/uploads/2017/11/comp-hover1.png

    Contract Genomics

  • https://www.genome.com/wp-content/uploads/2017/11/comp2.png
    https://www.genome.com/wp-content/uploads/2017/11/icon1-1.png

    Bioinformatics

  • https://www.genome.com/wp-content/uploads/2017/11/comp3.png
    https://www.genome.com/wp-content/uploads/2017/11/icon2-1.png

    Technology

Contract Genomics Research

Genome International carries out custom curation of biological databases, including genomic, proteomic, and disease genetics, for which sophisticated research is required. Each project is fit to the specific need of the customer, and delivered with multiple analysis tools to simplify and expedite the data analysis process.

  • Research Strategy and Experiment Design
  • High-quality reproducible genomic data analysis
  • Biologically meaningful interpretation
  • Scientific expertise to support projects

Bioinformatics

Genome International customizes bioinformatics strategies and models based on the requirements of researchers to carry out genomic analysis and interpretation backed by it’s proven research expertise.

  • Developing bioinformatic models
  • Custom Algorithms
  • Pipeline development
  • Genome Mapping
  • Variant Discovery
  • Gene Expression Analysis
  • Comparative Genome Analysis

Technology

Invented by the founder & CSO of Genome International, Dr. Periannan Senapathy, the Shapiro-Senapathy algorithm has been used to determine various aberrant splicing mechanisms in genes due to deleterious mutations in splice sites, which cause numerous diseases. Deleterious splice site mutations impair the normal splicing of the gene transcripts, and thereby make the encoded protein defective. Using the S&S algorithm, scientists have identified mutations and genes that cause numerous cancers, inherited disorders, immune deficiency diseases, and neurological disorders.

https://www.genome.com/wp-content/uploads/2017/11/comp1.png
https://www.genome.com/wp-content/uploads/2017/11/comp-hover1.png

Contract Genomics

Contract Genomics Research

Genome International carries out custom curation of biological databases, including genomic, proteomic, and disease genetics, for which sophisticated research is required. Each project is fit to the specific need of the customer, and delivered with multiple analysis tools to simplify and expedite the data analysis process.

  • Research Strategy and Experiment Design
  • High-quality reproducible genomic data analysis
  • Biologically meaningful interpretation
  • Scientific expertise to support projects

https://www.genome.com/wp-content/uploads/2017/11/comp2.png
https://www.genome.com/wp-content/uploads/2017/11/icon1-1.png

Bioinformatics

Bioinformatics

Genome International customizes bioinformatics strategies and models based on the requirements of researchers to carry out genomic analysis and interpretation backed by it’s proven research expertise.

  • Developing bioinformatic models
  • Custom Algorithms
  • Pipeline development
  • Genome Mapping
  • Variant Discovery
  • Gene Expression Analysis
  • Comparative Genome Analysis

https://www.genome.com/wp-content/uploads/2017/11/comp3.png
https://www.genome.com/wp-content/uploads/2017/11/icon2-1.png

Technology

Technology

Invented by the founder & CSO of Genome International, Dr. Periannan Senapathy, the Shapiro-Senapathy algorithm has been used to determine various aberrant splicing mechanisms in genes due to deleterious mutations in splice sites, which cause numerous diseases. Deleterious splice site mutations impair the normal splicing of the gene transcripts, and thereby make the encoded protein defective. Using the S&S algorithm, scientists have identified mutations and genes that cause numerous cancers, inherited disorders, immune deficiency diseases, and neurological disorders.